Why Ultragenyx Pharmaceutical Stock Is Bouncing Back Today
While Pharmaceutical (NASDAQ: RARE) provided the market with disappointing news yesterday -- shares plunged more than 42% -- it appears that investors aren't completely writing off the company's potential as a developer of treatments for rare diseases. A firm's favorable view of Ultragenyx stock is motivating some investors to click the buy button today, helping the stock recover from its recent decline.
As of 2:51 p.m. ET, shares of Ultragenyx are up 13.2%.
Image source: Getty Images.
Source Fool.com
Ultragenyx Pharmaceutical Inc. Aktie
19,30 €
5,46 %
Klares Signal: Ultragenyx Pharmaceutical Inc. wird ausschließlich zum Kauf empfohlen.
Für Ultragenyx Pharmaceutical Inc. sieht die Community ein Kursziel von 55 €, was mehr als das Doppelte des aktuellen Kurses von 19.3 € ausmacht.
